Review of the factors affecting bioavailability of soy isoflavones in humans

Nutrition and Cancer

Volumn 57, Issue 1, 2007, Pages 1-10

  Nielsen, Inge Lise Finné ^a   Williamson, Gary ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; DAIDZEIN; DAIDZIN; DENISTIN; EQUOL; ESTROGEN RECEPTOR; GENISTEIN; GENISTIN; GLUCOSIDE; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BIOAVAILABILITY; BLOOD LEVEL; GASTROINTESTINAL ABSORPTION; HALF LIFE TIME; HUMAN; POSTMENOPAUSE; PREMENOPAUSE; REVIEW; SOYBEAN; SYSTEMATIC REVIEW; URINARY EXCRETION;

EID: 34249897244     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701267677     Document Type: Review

References (45)

1. Setchell KD and Lydeking-Olsen E: Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 78, S593-S609, 2003.
2. Setchell KD and Cassidy A: Dietary isoflavones: biological effects and relevance to human health.J Nutr 129, S758-S767, 1999.
3. Setchell KD: Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68, S1333-S1346, 1998.
4. Messina MJ and Loprinzi CL: Soy for breast cancer survivors: a critical review of the literature. J Nutr 131, S3095-S3108, 2001.
5. Vitolins MZ: Effects of soy protein in menopausal women: a review. Agro Food Ind High-Tech 14, 12-16, 2003.
6. Manach C, Williamson G, Morand C, Scalbert A, and Remesy C: Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, S230-S242, 2005.
7. Day AJ, Canada FJ, Diaz JC, Kroon PA, McLauchlan WR, et al.: Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 468, 166-170, 2000.
8. King RA and Bursill DB: Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr 67, 867-872, 1998.
9. Piskula MK: Soy isoflavone conjugation differs in fed and food-deprived rats. J Nutr 130, 1766-1771, 2000.
10. Setchell KD, Brown NM, and Lydeking-Olsen E: The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr 132, 3577-3584, 2002.
11. Lampe JW, Karr SC, Hutchins AM, and Slavin JL: Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 217, 335-339, 1998.
12. Hutchins AM, Slavin JL, and Lampe JW: Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J Am Diet Assoc 95, 545-551, 1995.
13. Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, et al.: Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr 130, 1695-1699, 2000.
14. Richelle M, Pridmore-Merten S, Bodenstab S, Enslen M, and Offord EA: Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J Nutr 132, 2587-2592, 2002.
15. Zubik L and Meydani M: Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr 77, 1459-1465, 2003.
16. Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, et al.: Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 131, S1362-S1375, 2001.
17. Busby MG, Jeffcoat AR, Bloedon LT, Koch MA, Black T, et al.: Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr 75, 126-136, 2002.
18. Zheng Y, Hu J, Murphy PA, Alekel DL, Franke WD, et al.: Rapid gut transit time and slow fecal isoflavone disappearance phenotype are associated with greater genistein bioavailability in women. J Nutr 133, 3110-3116, 2003.
19. Zhang Y, Wang GJ, Song TT, Murphy PA, and Hendrich S: Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity. J Nutr 129, 957-962, 1999; erratum 1 J Nutr 131, 147, 2001.
20. Faughnan MS, Hawdon A, Ah-Singh E, Brown J, Millward DJ, et al.: Urinary isoflavone kinetics: the effect of age, gender, food matrix and chemical composition. Br J Nutr 91, 567-574, 2004.
21. Xu X, Wang HJ, Murphy PA, and Hendrich S: Neither background diet nor type of soy food affects short-term isoflavone bioavailability in women. J Nutr 130, 798-801, 2000.
22. Tew BY, Xu X, Wang HJ, Murphy PA, and Hendrich S: A diet high in wheat fiber decreases the bioavailability of soybean isoflavones in a single meal fed to women. J Nutr 126, 871-877, 1996.
23. Setchell KD, Faughnan MS, Avades T, Zimmer-Nechemias L, Brown NM, et al.: Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 77, 411-419, 2003.
24. Zhang Y, Hendrich S, and Murphy PA: Glucuronides are the main isoflavone metabolites in women. J Nutr 133, 399-404, 2003.
25. Shelnutt SR, Cimino CO, Wiggins PA, Ronis MJJ, and Badger TM: Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am J Clin Nutr 76, 588-594, 2002.
26. Lu LJ and Anderson KE: Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans. Am J Clin Nutr 68, S1500-S1504, 1998.
27. Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, et al.: Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 133, 1027-1035, 2003.
28. Setchell KD, Zimmer-Nechemias L, Cai J, and Heubi JE: Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 350, 23-27, 1997.
29. Xu X, Harris KS, Wang HJ, Murphy PA, and Hendrich S: Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 125, 2307-2315, 1995.
30. Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, et al.: Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60g baked soybean powder (kinako). Am Soc Nutr Sci 128, 1710-1715, 1998.
31. Setchell KD, Borriello SP, Hulme P, Kirk DN, and Axelson M: Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 40, 569-578, 1984.
32. Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hamalainen E, et al.: Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 54, 1093-1100, 1991.
33. Rowland I, Wiseman H, Sanders T, Adlercreutz H, and Bowey E: Metabolism of oestrogens and phytoestrogens: role of the gut microflora. Biochem Soc Trans 27, 304-308, 1999.
34. de Pascual Teresa S, Hallund J, Talbot D, Schroot J, Williams C, et al.: Absorption of isoflavones in humans: effects of food matrix and processing. J Nutr Biochem 17, 257-264, 2006.
35. Johns P, Dowlati L, and Wargo W: Determination of isoflavones in ready-to-feed soy-based infant formula. J AOAC Int 86, 72-78, 2003.
36. Lee SJ, Ahn JK, Kim SH, Kim JT, Han SJ, et al.: Variation in isoflavone of soybean cultivars with location and storage duration. J Agric Food Chem 51, 3382-3389, 2003.
37. Eisen B, Ungar Y, and Shimoni E: Stability of isoflavones in soy milk stored at elevated and ambient temperatures. J Agric Food Chem 51, 2212-2215, 2003.
38. Xu ZM, Wu Q, and Godber JS: Stabilities of daidzin, glycitin, genistin, and generation of derivatives during heating. J Agric Food Chem 50, 7402-7406, 2002.
39. Mahungu SM, Diaz-Mercado S, Li J, Schwenk M, Singletary K, et al.: Stability of isoflavones during extrusion processing of corn/soy mixture. J Agric Food Chem 47, 279-284, 1999.
40. Walsh KR, Zhang YC, Vodovotz Y, Schwanz SJ, and Failla ML: Stability and bioaccessibility of isoflavones from soy bread during in vitro digestion. J Agric Food Chem 51, 4603-4609, 2003.
41. Li D, Park JH, Park JT, Park CS, and Park KH: Biotechnological production of highly soluble daidzein glycosides using Thermotoga maritima maltosyltransferase. J Agric Food Chem 52, 2561-2567, 2004.
42. Xu X, Wang HJ, Murphy PA, Cook L, and Hendrich S: Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124, 825-832, 1994.
43. Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, et al.: Bioavailability of phyto-oestrogens. Br J Nutr 89 (suppl 1), 838-852, 2003.
44. Faughnan MS, Hawdon A, Ah-Singh E, Brown J, Millward DJ, et al.: Urinary isoflavone kinetics: the effect of age, gender, food matrix, and chemical composition. Br J Nutr 91, 567-574, 2004.
45. Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, et al.: Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 131, S1362-S1375, 2001.